Asian markets are mostly trading lower on Thursday as investors are waiting for updates on US trade negotiations. The uncertainty surrounding trade policies, particularly those related to US tariff under Donal Trump is causing investors to be cautious.

US markets were drifting on Wednesday as Donald Trump's Gulf tour stocked hopes of a more trade deal.

Here's a table showing how US stocks performed on Wednesday:

Source: Equitymaster

At present, the BSE Sensex is trading 563 points lower, and the NSE Nifty is trading 110 points lower.

Adani Port, Tech Mahindra, UltraTech Cement among the top gainers today

Power Grid Corp, IndusInd Bank, and Kotak Mahindra, on the other hand, are among the top losers today.

The BSE MidCap index ended 0.3% higher, and the BSE SmallCap index ended 0.6% higher.

Sectoral indices were trading mixed today, with stocks in the realty sector and the banking sector witnessing selling pressure. Meanwhile, stocks in the metal sector and the services sector witness buying.
 

Tata Power Q4 Profit Jumps 25%

Tata Power, an integrated private power company, reported a 25% increase in net profit to Rs 13.1 billion (bn) for Q4FY25 on Wednesday, riding the growth of its solar business.

During the same period, the company's revenue increased by 7% to Rs 173.2 bn.

Tata Power said in a statement that "the overall growth was greatly aided by higher power sales from all generating plants, ramp-up of all module and cell lines in Tirunelveli, and significant strides in the solar rooftop business pan-India, achieving the 1.5 lakh installation milestone.

In FY25, the company made a 26% increase in revenue to a record Rs 645 bn and a profit of Rs 51.9 bn.

The company has a robust rooftop solar business with 3 GW capacity and more than 150,000 installations, and it is committed to renewable energy, with a target of 2 GW capacity by FY26.

In FY25, it also contributed to India's rising energy demand by supplying the grid with more than 64.7 billion units of electricity.

Apollo Tyres Reports Decline in Profit

Apollo Tyres reported Q4FY25 net profit of Rs 1.9 bn, a 47.8% decrease from the Rs 3.5 bn compared to same period last year.

In Q4FY25, the tyre manufacturer reported total income of 64.5 bn, a 1.8% YoY increase compared to Rs 63.3 bn in the same quarter last year.

Total expenses increased by 5.9% to Rs 60.7 bn.

For FY25, the Board of Directors recommended a dividend of Rs 5 per share, on the face value of Rs 1 per share. Approval from shareholders will be done in upcoming general meeting.

The total income for FY25 was Rs 262.12 bn, up 2.5% year- over- year from Rs 255.3 bn compared to FY24.

Also, EBITDA decline to 13% from 16.4 in the same quarter last year. The operating margin declined from 17.52% in FY24 to 13.67% for the entire year FY25.
 

JB Pharma Q4 profit and Revenue Up

JB Chemicals and Pharmaceuticals reported a 15% year-over-year (Y-o-Y) increase in net profit for Q4 FY25, reaching Rs 1.5bn, while operating revenue increased 10% Y-o-Y to Rs 9.49 bn.

Revenue fell 1.4% and net profit fell 10.3% sequentially.

Consolidated net profit increased 19.3% to Rs 6.6 bn for FY25, while operating revenue jumped 12.4% to Rs 39.2bn.

The company's domestic business grew 11% year over year to Rs 5.19 bn in Q4.

JB Pharma's Y-o-Y growth of 13% was almost twice as high as the 7% growth of the Indian Pharmaceutical Market (IPM).

JB Pharma saw a 12% growth excluding ophthalmology, with prescription volumes rising 7%. The chronic segment grew 16%. Ophthalmology stood out with 22% growth of Rs 0.6 bn.

Additionally, the international business revenue increased 9% to Rs 4.3 bn driven by strong performance in markets like Russia.

Domestic business grew 20% to Rs 22.7 bn, driven by demand across various therapeutic areas. Excluding ophthalmology, the growth was 13%.

JB Pharma's Contract Development and Manufacturing Organization (CDMO) segment rose 18% to Rs 1.3 bn and has a strong order pipeline. However, the Active Pharmaceutical Ingredient (API) business had lower sales of Rs 0.2 bn.

More By This Author: